BridgeBio Oncology Therapeutics Inc.
Industry: Health Care – Biotechnology: Pharmaceutical Preparations
Stock Symbol: BBOT – NASDAQ
Animal Usage: Animal Testing
Our Opinion
Animal Exploitation (Testing): Yes Link: BridgeBio Oncology Therapeutics Presents Preclinical Data on BBO-10203 Inhibiting RAS-PI3Kα Interaction and Showing Promise in Cancer Treatment – Quiver Quantitative Short Description: BridgeBio Oncology Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel cancer therapies. As a drug development company, it conducts preclinical studies on its drug candidates, which involves animal testing using various animal cancer models to test efficacy and safety before progressing to human clinical trials.